A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

CompletedOBSERVATIONAL

Enrollment

26,774

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

June 16, 2022

Study Completion Date

June 16, 2022

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Empagliflozin

new users (initiators) of Empagliflozin

DRUG

Liraglutide

initiators of Liraglutide

Trial Locations (1)

Department of Clinical Epidemiology - Aarhus Unversiteteshospital, Aarhus